Discover how the Inflation Reduction Act has so far saved 1.5 million Medicare Part D enrollees nearly $1 billion in out-of-pocket prescription drug costs.
On October 8, 2024, PhRMA held a media briefing to address growing concerns over the Inflation Reduction Act (IRA) and its effects on the biopharmaceutical industry, Medicare Part D beneficiaries, and ...